A carregar...

Combination Immunotherapy for Tumors via Sequential Intratumoral Injections of Oncolytic Herpes Simplex Virus 1 and Immature Dendritic Cells

PURPOSE: Oncolytic herpes simplex virus 1 (oHSV) vectors treat tumors in preclinical models and have been used safely in phase I clinical trials for patients with cancer. Infection of tumors with oHSV also induces specific antitumor immunity. We investigated whether this immunotherapeutic effect is...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Farrell, Christopher J., Zaupa, Cecile, Barnard, Zachary, Maley, Jason, Martuza, Robert L., Rabkin, Samuel D., Curry, William T.
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2670995/
https://ncbi.nlm.nih.gov/pubmed/19047097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-1364
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!